Anebulo Pharmaceuticals (ANEB) Return on Assets [ROA] (2021 - 2025)
Anebulo Pharmaceuticals (ANEB) posted Return on Assets [ROA] of -89.44% for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 0.37 percentage points from -89.81% a year earlier but down 9.53 percentage points from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Return on Assets [ROA] (2021 - 2025) Analysis & Trends
For FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals' Return on Assets [ROA] came in at -115.49%, down 10.56 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for four consecutive fiscal years, with a four-year change of -86.21 percentage points (FY2021 to FY2025).
- In prior fiscal years, Anebulo Pharmaceuticals' Return on Assets [ROA] was -104.93% in FY2024 (-19.12 pp), -85.81% in FY2023 (-49.15 pp), -36.65% in FY2022 (-7.37 pp) and -29.28% in FY2021.
- Quarterly Return on Assets [ROA] has run from a low of -252.48% in fiscal Q1 2025 to a high of -23.29% in fiscal Q1 2022 over five years.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last five quarters, with an average year-over-year change of +12.80 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was fiscal Q1 2026, with a gain of 172.57 percentage points; the weakest was fiscal Q1 2025, with a drop of 140.77 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior fiscal quarters was -79.91% (Q1 2026), -72.23% (Q4 2025) and -57.63% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | -89.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -89.44% |
| Sep 30, 2025 | -79.91% |
| Jun 30, 2025 | -72.23% |
| Mar 31, 2025 | -57.63% |
| Dec 31, 2024 | -89.81% |
| Sep 30, 2024 | -252.48% |
| Jun 30, 2024 | -164.07% |
| Mar 31, 2024 | -138.64% |
| Dec 31, 2023 | -126.71% |
| Sep 30, 2023 | -111.71% |
| Jun 30, 2023 | -89.61% |
| Mar 31, 2023 | -73.60% |
| Dec 31, 2022 | -57.88% |
| Sep 30, 2022 | -44.57% |
| Jun 30, 2022 | -41.62% |
| Mar 31, 2022 | -38.54% |
| Dec 31, 2021 | -28.66% |
| Sep 30, 2021 | -23.29% |
| Jun 30, 2021 | -27.79% |
API Access
Anebulo Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();